Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2000

View Archived Issues

Activity of tucaresol determined in mouse models of visceral leishmaniasis

AIDS vaccine designed for Africa to begin phase I testing

HERS study shows increased venous thromboembolic risk with HRT

SkyePharma and Kirin Brewery enter drug delivery contract

Cafcit reduces apnea of prematurity

FDA advisory committee recommends against approval of OTC Mevacor

New formulations of RenaGel approved for use by FDA

LMWH such as enoxaparin claimed for use in motor neuron diseases

Company Profile: AGY Therapeutics

Profile of new melatonin agonist TAK-375 with natural-type effects on sleep

Microbially produced macrolide antifungal agent discovered in Spain

SNAP-7915: a promising new therapy for BPH designed by Synaptic and Merck team

Biopure reaches enrollment milestone in pivotal phase III trial of Hemopure

CETP inhibitor JTT-705 favorably affects lipid profiles, prevents progression of atherosclerosis

Pharmacopeia achieves milestone in Organon collaboration

Chiron and Aventis Pasteur team up to promote and market vaccines

Santarus initiates phase II trial of delayed-release azathioprine for treatment of Crohn's disease

Design, synthesis and biological profile of selective adenosine A2A agonist reported at Purines 2000

Abbott develops novel, orally active AK inhibitor with analgesic and antiinflammatory properties

New formulation of perospirone examined for efficacy and safety in schizophrenic patients

The former Warner-Lambert claims use of MEK kinase inhibitors for transplant rejection

Potassium channel modulators with antiischemic activity identified at BMS

Berlex presents newly synthesized series of anticoagulants

Novel DPP-IV inhibitors and their potential in NIDDM

Analgesic activity described for substituted cycloheptenes synthesized at Gruenenthal

Potent, broad-spectrum carbapenems in development at Sankyo

Takeda's new neuroprotectants useful for Alzheimer's disease and Parkinson's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...